title: Sterol carrier protein-2 alters high density lipoprotein-mediated cholesterol efflux.
abstract: Although sterol carrier protein-2 (SCP-2) participates in the uptake and intracellular trafficking of cholesterol, its effect on "reverse cholesterol transport" has not been explored. As shown herein, SCP-2 expression inhibited high density lipoprotein (HDL)-mediated efflux of [(3)H]cholesterol and fluorescent 22-(N-(7-nitrobenz-2-oxa-1, 3-diazol-4-yl)amino)-23,24-bisnor-5-cholen-3b-ol (NBD-cholesterol) up to 61 and 157%, respectively. Confocal microscopy of living cells allowed kinetic analysis of two intracellular pools of HDL-mediated NBD-cholesterol efflux: the highly fluorescent lipid droplet pool and the less fluorescent pool outside the lipid droplets, designated the cytoplasmic compartment. Both the whole cell and the cytoplasmic compartment exhibited two similar kinetic pools, the half-times of which were consistent with protein (t(b)(12) near 1 min) and vesicular (t(d)(12) = 10-20 min) mediated sterol transfer. Although SCP-2 expression did not alter cytoplasmic sterol pool sizes, the rapid t(b)(12) decreased 36%, while the slower t(d)(12) increased 113%. Lipid droplets also exhibited two kinetic pools of NBD-cholesterol efflux but with half-times over 200% shorter than those of the cytoplasmic compartment. The lipid droplet slower effluxing pool size and t(d)(12) were increased 48% and 115%, respectively, in SCP-2-expressing cells. Concomitantly, the level of the lipid droplet-specific adipose differentiation-related protein decreased 70%. Overall, HDL-mediated sterol efflux from L-cell fibroblasts reflected that of the cytoplasmic rather than lipid droplet compartment. SCP-2 differentially modulated sterol efflux from the two cytoplasmic pools. However, net efflux was determined primarily by inhibition of the slowly effluxing pool rather than by acceleration of the rapid protein-mediated pool. Finally, SCP-2 expression also inhibited sterol efflux from lipid droplets, an effect related to decreased adipose differentiation-related protein, a lipid droplet surface protein that binds cholesterol with high affinity.
authors.affiliation: Department of Physiology and Pharmacology and the Department of Pathobiology, Texas A & M University, College Station, Texas 77843-4466, USA.
authors.forename: B P
authors.initials: BP
authors.lastname: Atshaves
authors.forename: O
authors.initials: O
authors.lastname: Starodub
authors.forename: A
authors.initials: A
authors.lastname: McIntosh
authors.forename: A
authors.initials: A
authors.lastname: Petrescu
authors.forename: J B
authors.initials: JB
authors.lastname: Roths
authors.forename: A B
authors.initials: AB
authors.lastname: Kier
authors.forename: F
authors.initials: F
authors.lastname: Schroeder
mesh_terms: D009327:4-Chloro-7-nitrobenzofurazan / Q000031:analogs & derivatives / Q000378:metabolism; D000818:Animals; D015153:Blotting, Western; D002352:Carrier Proteins / Q000378:metabolism*; D002451:Cell Compartmentation; D002784:Cholesterol / Q000031:analogs & derivatives / Q000378:metabolism*; D007739:L Cells; D008075:Lipoproteins, HDL / Q000378:metabolism*; D051379:Mice; D018613:Microscopy, Confocal; D010940:Plant Proteins; D014162:Transfection
chemical_list: C077527:7-nitrobenz-2-oxa-1,3-diazol-4-ylcholesterol; D002352:Carrier Proteins; D008075:Lipoproteins, HDL; D010940:Plant Proteins; C072087:sterol carrier proteins; D002784:Cholesterol; D009327:4-Chloro-7-nitrobenzofurazan